Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFT Study 2: NPC-06 for Acute Exacerbation of Trigeminal Neuralgia
jRCT2011250056Phase 3Recruiting
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jan 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in trigeminal neuralgia (TN) and Idiopathic Trigeminal Neuralgia (TN) comparing NPC-06 arm with Placebo arm (2 arms). Started Jan 2026; status: recruiting.
02
Drugs
fosphenytoin
03
Conditions
trigeminal neuralgia (TN)Idiopathic Trigeminal Neuralgia (TN)
Beyond the preview
Go deeper on jRCT2011250056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011250056.